Foundation Medicine, Inc.
FMI
FMI was delisted on the 30th of July, 2018.
89 hedge funds and large institutions have $224M invested in Foundation Medicine, Inc. in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 31 increasing their positions, 26 reducing their positions, and 16 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 26
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 96 → 89 (-7)
43% less capital invested
Capital invested by funds: $397M → $224M (-$173M)
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
92% less call options, than puts
Call options by funds: $1.3M | Put options by funds: $15.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MRM
Michael R. Murphy
|
+$27.1M |
| 2 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
+$24.4M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$16.2M |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$5.91M |
| 5 |
ST
Spot Trading
Chicago,
Illinois
|
+$5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$36.5M |
| 2 |
State Street
Boston,
Massachusetts
|
-$19.4M |
| 3 |
BAMCO Inc
New York
|
-$7.36M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$7.07M |
| 5 |
CPM
Chesapeake Partners Management
Baltimore,
Maryland
|
-$6.47M |
FMI Hedge Fund Activity: Q3 2015 in Review
89 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q3 2015, worth a combined $224M — down 43% from $397M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of FMI and 9 opened new positions — a net loss of 7 holders — while 26 trimmed existing stakes and 31 added.
The largest buyer was Michael R. Murphy, opening a new position worth an estimated $27.1M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $36.5M.
- 89 institutional investors held Foundation Medicine, Inc. (FMI) as of Q3 2015, down from 96 in Q2 2015.
- Funds reported $224M of Foundation Medicine, Inc. stock for Q3 2015, down 43% quarter-over-quarter.
- 9 funds opened new Foundation Medicine, Inc. positions in Q3 2015 and 16 closed out, a net change of -7 holders.
- The largest Foundation Medicine, Inc. buyer in Q3 2015 was Michael R. Murphy, an estimated $27.1M added.
- The largest Foundation Medicine, Inc. seller in Q3 2015 was Gilder Gagnon Howe & Co, an estimated $36.5M sold.
Based on aggregated 13F filings for Q3 2015.